Related Experiment Video
Updated: Mar 18, 2026

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
Published on: November 17, 2015
Topically applied lipid- and surfactant-based nanoparticles in the treatment of skin disorders
Eline Desmet1, Mireille Van Gele1, Jo Lambert1
1a Department of Dermatology , Ghent University Hospital , Ghent , Belgium.
Introduction:
In the treatment of dermatological disorders, topical drug administration is a mainstay. However, nanoparticle-based carrier systems could improve and expand the current therapeutic range via localized delivery of active ingredients. Areas covered: This review gives a detailed description of lipid- and surfactant-based drug delivery systems which have been explored for topical drug administration. To guide researchers in their choice of delivery system, an informative decision tree is included. Moreover, this review provides a complete overview of the topical or transdermal drug products, currently on the market or under clinical investigation, delivered via the discussed carriers, in the treatment of skin disorders. Expert opinion: Conventional liposomes are still popular in the domain of topical or transdermal drug delivery and dominate the market landscape. However, several other carriers, such as exosomes and niosomes, are being explored which offer distinct advantages over liposomes and should therefore not be disregarded when selecting a proper drug delivery system.
Related Concept Videos
Micelles
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Surface Active Agents
Bioavailability Enhancement: Drug Permeability Enhancement

